Health Canada has granted CooperVision, Inc. approval for its new Biofinity® toric multifocal contact lenses.
The highly-anticipated product combines the proven optical designs of CooperVision’s Biofinity® toric—the lens you can count on —and Biofinity® multifocal, to provide patients with both the astigmatism and presbyopia vision correction they deserve. The company plans to make the lenses available to Canadian eye care professionals later this year.
“Biofinity toric multifocal extends the reliable performance of our Biofinity toric lenses to presbyopic patients,” said Michele Andrews, OD, Senior Director, Professional and Academic Affairs, North America, CooperVision. “Canadian eye care professionals will soon have an easy-to-fit, familiar lens design they can count on to keep current toric wearers satisfied in contact lenses for longer, and provide new astigmatic wearers an alternative to reading glasses. It’s a win-win for practitioners and their patients.”
Lens parameters and other details regarding Biofinity® toric multifocal will be made public in the coming months. For more information, visit mycoopervision.ca.
